Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia
NCT01437202
·
clinicaltrials.gov ↗
COMPLETED
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Sponsor
Asan Medical Center